Why is Guj. Terce Labs. falling/rising?

As of 21-Aug, Gujarat Terce Laboratories Ltd is experiencing a price increase, currently at 43.88, reflecting a change of 0.68 or 1.57% upward. The stock has outperformed its sector today by 1.11%, although it is trading higher than its 5-day moving average but lower than its 20-day, 50-day, 100-day, and 200-day moving averages. Despite this positive movement, the stock has shown a significant decline over the past month, with a return of -11.76%, and a year-to-date drop of -48.25%. The company's financial health is concerning, as it has reported operating losses and a weak ability to service its debt, with a poor EBIT to Interest ratio of 0.02. Additionally, the stock has underperformed the market over the last year, with a return of -13.96% compared to the BSE500's -1.56%. In the broader market context, the stock's short-term performance of +5.73% over the past week is notably stronger than the Sensex's +1.74% during the same period. However, the overall trend remains negative, as the stock has significantly lagged behind the benchmark in the longer term, particularly with a year-to-date decline of -48.25% compared to the Sensex's +4.94%. The company's weak fundamentals, including a low return on equity of -15.3 and a high price-to-book value of 5.3, contribute to its expensive valuation and suggest that the recent price increase may not be sustainable in light of its ongoing operational challenges.